Paranovus Entertainment Technology Ltd.

PAVS

NASDAQHealthcareMedical - Pharmaceuticals

Open in GoAI

Latest quote

$3.64

$0.00 · 0.00%

Company profile

Paranovus Entertainment Technology Ltd. operates in the artificial intelligence (AI)-powered entertainment industry. The company focuses on providing AI-driven games and applications. The company was formerly known as Happiness Development Group Limited and changed its name to Paranovus Entertainment Technology Ltd. in March 2023. Paranovus Entertainment Technology Ltd. was founded in 2004 and is based in New York, New York.

Paranovus Entertainment Technology Ltd.

PAVS

NASDAQHealthcareMedical - Pharmaceuticals

Open in GoAI

Previous close

$3.64

$0.00 · 0.00%

Oct 9, 4:00 PM ET

Latest quote

$3.64

$0.00 · 0.00%

After-hours

$3.54

−$0.10 · -2.75%

Oct 9, 7:58 PM ET

Regular session · ET · Market data may be delayed.

GoAI snapshot

Jul 10, 2026

36/ 100

GoAI Score

Sell

Valuation

Fair Value

Sentiment

Mixed

Risk

High Risk

Momentum

Weakening

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

Company profile

Company website

Industry: Medical - Pharmaceuticals
Sector: Healthcare
Headquarters: US
CEO: Xiaoyue Zhang
Listed since: Oct 25, 2019
Employees: 29

Market position

Day range

Current $3.64

$3.59$3.705

52-week range

Current $3.64

$3.5401$148,800

Open: $3.62
Previous close: $3.64
Volume: 14.37K; 0.02× average
Average volume: 904.73K; Average daily volume
Market cap: 3.12M USD
Beta: -0.14; Market reference 1
50-day average: $4.9231; -26.06% below average
200-day average: $592.1; -99.39% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM): -0×
P/B (TTM): 0×
P/S (TTM): 0.21×
Dividend yield: 0.00%

Profitability & efficiency

Gross margin: 1.04%
Operating margin: -23.11%
Net margin: -87.20%

Financial health

Debt / equity: 0.02×

Earnings

EPS beat rate: 0%; 0 beats, 6 misses, 0 met estimates
Average EPS surprise: -104.30%; 6 comparable reports
Latest EPS result: -75.22

EPS: actual versus estimate

Recent quarterly results

ActualEstimate

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate

Corporate actions

Corporate action history

Action	Ex-dividend date	Details	Record date	Payment date
Dividend	Aug 7, 2020	$0.015Special	Aug 10, 2020	Aug 17, 2020

Dividend

Ex-dividend Aug 7, 2020

$0.015

Special

Record Aug 10, 2020 · Payment Aug 17, 2020

PAVS peers

AMGN

Amgen Inc.

$414.87

+1.82%

GILD

Gilead Sciences, Inc.

$151.17

+2.77%

ISRG

Intuitive Surgical, Inc.

$423.96

+2.06%

VRTX

Vertex Pharmaceuticals Incorporated

$510.08

+1.36%

SNY

Sanofi

$40.07

-0.40%

MRNA

Moderna, Inc.

$225

+14.21%

Continue in GoAI

Research PAVS

AI-generated and delayed market data for informational and educational purposes only. Not investment advice.

Regular session · ET · Market data may be delayed.

Company profile

Company website

Industry: Medical - Pharmaceuticals
Sector: Healthcare
Headquarters: US
CEO: Xiaoyue Zhang
Listed since: Oct 25, 2019
Employees: 29

Market position

Day range

Current $3.64

$3.59$3.705

52-week range

Current $3.64

$3.5401$148,800

Open: $3.62
Previous close: $3.64
Volume: 14.37K; 0.02× average
Average volume: 904.73K; Average daily volume
Market cap: 3.12M USD
Beta: -0.14; Market reference 1
50-day average: $4.9231; -26.06% below average
200-day average: $592.1; -99.39% below average

Company profile

Regular session · ET · Market data may be delayed.

GoAI snapshot

Jul 10, 2026

36/ 100

GoAI Score

Sell

Valuation

Fair Value

Sentiment

Mixed

Risk

High Risk

Momentum

Weakening

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

Company profile

Company website

Industry: Medical - Pharmaceuticals
Sector: Healthcare
Headquarters: US
CEO: Xiaoyue Zhang
Listed since: Oct 25, 2019
Employees: 29

Market position

Day range

Current $3.64

$3.59$3.705

52-week range

Current $3.64

$3.5401$148,800

Open: $3.62
Previous close: $3.64
Volume: 14.37K; 0.02× average
Average volume: 904.73K; Average daily volume
Market cap: 3.12M USD
Beta: -0.14; Market reference 1
50-day average: $4.9231; -26.06% below average
200-day average: $592.1; -99.39% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM): -0×
P/B (TTM): 0×
P/S (TTM): 0.21×
Dividend yield: 0.00%

Profitability & efficiency

Gross margin: 1.04%
Operating margin: -23.11%
Net margin: -87.20%

Financial health

Debt / equity: 0.02×

Earnings

EPS beat rate: 0%; 0 beats, 6 misses, 0 met estimates
Average EPS surprise: -104.30%; 6 comparable reports
Latest EPS result: -75.22

EPS: actual versus estimate

Recent quarterly results

ActualEstimate

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate

Corporate actions

Corporate action history

Action	Ex-dividend date	Details	Record date	Payment date
Dividend	Aug 7, 2020	$0.015Special	Aug 10, 2020	Aug 17, 2020

Dividend

Ex-dividend Aug 7, 2020

$0.015

Special

Record Aug 10, 2020 · Payment Aug 17, 2020

PAVS peers

AMGN

Amgen Inc.

$414.87

+1.82%

GILD

Gilead Sciences, Inc.

$151.17

+2.77%

ISRG

Intuitive Surgical, Inc.

$423.96

+2.06%

VRTX

Vertex Pharmaceuticals Incorporated

$510.08

+1.36%

SNY

Sanofi

$40.07

-0.40%

MRNA

Moderna, Inc.

$225

+14.21%

Continue in GoAI

Research PAVS

AI-generated and delayed market data for informational and educational purposes only. Not investment advice.

Paranovus Entertainment Technology Ltd.

PAVS company overview

Company profile

Paranovus Entertainment Technology Ltd.

PAVS company overview

GoAI snapshot

Company profile

Market position

Financials

Financial snapshot

Valuation & yield

Profitability & efficiency

Financial health

Earnings

EPS: actual versus estimate

Revenue: actual versus estimate

Corporate actions

Corporate action history

PAVS peers

Continue in GoAI

PAVS company overview

Company profile

Market position

PAVS company overview

Company profile

PAVS company overview

Company profile

Market position

PAVS company overview

GoAI snapshot

Company profile

Market position

Financials

Financial snapshot

Valuation & yield

Profitability & efficiency

Financial health

Earnings

EPS: actual versus estimate

Revenue: actual versus estimate

Corporate actions

Corporate action history

PAVS peers

Continue in GoAI